These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16266123)

  • 21. IMP dehydrogenase basal activity in MOLT-4 human leukaemia cells is altered by mycophenolic acid and 6-thioguanosine.
    Vethe NT; Bremer S; Bergan S
    Scand J Clin Lab Invest; 2008; 68(4):277-85. PubMed ID: 18609073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A conserved molecular action of native and recombinant Epap-1 in inhibition of HIV-1 gp120 mediated viral entry.
    Roda Rani KP; Pelluru D; Kondapi AK
    Arch Biochem Biophys; 2006 Dec; 456(1):79-92. PubMed ID: 17078922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human glutaredoxin-1 catalyzes the reduction of HIV-1 gp120 and CD4 disulfides and its inhibition reduces HIV-1 replication.
    Auwerx J; Isacsson O; Söderlund J; Balzarini J; Johansson M; Lundberg M
    Int J Biochem Cell Biol; 2009 Jun; 41(6):1269-75. PubMed ID: 19038358
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are blockers of gp120/CD4 interaction effective inhibitors of HIV-1 immunopathogenesis?
    Herbeuval JP; Shearer GM
    AIDS Rev; 2006; 8(1):3-8. PubMed ID: 16736946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role of Arg59 in the high-affinity gp120-binding region of CD4 for human immunodeficiency virus type 1 infection.
    Fontenot D; Jones JK; Hossain MM; Nehete PN; Vela EM; Dwyer VA; Jagannadha Sastry K
    Virology; 2007 Jun; 363(1):69-78. PubMed ID: 17320923
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of mycophenolic acid on inosine monophosphate dehydrogenase I and II mRNA expression in white blood cells and various tissues in sheep.
    Dzidic A; Prgomet C; Mohr A; Meyer K; Bauer J; Meyer HH; Pfaffl MW
    J Vet Med A Physiol Pathol Clin Med; 2006 May; 53(4):163-9. PubMed ID: 16629948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The antiviral action of recombinant forms of the human T-lymphocyte CD4 receptor].
    Zverev VV; Maliushova VV; Sidorov AV; Pugach AV; Shukhmina NR; Pille ER; Mel'nikova NL; Andzhaparidze OG
    Vopr Virusol; 1994; 39(2):56-9. PubMed ID: 7517083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activity of ribavirin against Hantaan virus correlates with production of ribavirin-5'-triphosphate, not with inhibition of IMP dehydrogenase.
    Sun Y; Chung DH; Chu YK; Jonsson CB; Parker WB
    Antimicrob Agents Chemother; 2007 Jan; 51(1):84-8. PubMed ID: 17060520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genistein, a protein tyrosine kinase inhibitor, suppresses the fusogenicity of Moloney murine leukemia virus envelope protein in XC cells.
    Kubo Y; Ishimoto A; Amanuma H
    Arch Virol; 2003 Oct; 148(10):1899-914. PubMed ID: 14551814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of human prostate cancer PC-3 cells induced by inhibitors of inosine 5'-monophosphate dehydrogenase.
    Floryk D; Tollaksen SL; Giometti CS; Huberman E
    Cancer Res; 2004 Dec; 64(24):9049-56. PubMed ID: 15604271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The RhoGDI-alpha/JNK signaling pathway plays a significant role in mycophenolic acid-induced apoptosis in an insulin-secreting cell line.
    Park YJ; Ahn HJ; Chang HK; Kim JY; Huh KH; Kim MS; Kim YS
    Cell Signal; 2009 Feb; 21(2):356-64. PubMed ID: 19041939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual inhibitors of inosine monophosphate dehydrogenase and histone deacetylases for cancer treatment.
    Chen L; Wilson D; Jayaram HN; Pankiewicz KW
    J Med Chem; 2007 Dec; 50(26):6685-91. PubMed ID: 18038969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of inosine monophosphate dehydrogenase activity in human CD4+ cells isolated from whole blood during mycophenolic acid therapy.
    Vethe NT; Bergan S
    Ther Drug Monit; 2006 Oct; 28(5):608-13. PubMed ID: 17038874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained and specific in vitro inhibition of HIV-1 replication by a protease inhibitor encapsulated in gp120-targeted liposomes.
    Clayton R; Ohagen A; Nicol F; Del Vecchio AM; Jonckers TH; Goethals O; Van Loock M; Michiels L; Grigsby J; Xu Z; Zhang YP; Gutshall LL; Cunningham M; Jiang H; Bola S; Sarisky RT; Hertogs K
    Antiviral Res; 2009 Nov; 84(2):142-9. PubMed ID: 19699239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. F13459, a new derivative of mycophenolic acid. I. Taxonomy, isolation, and biological properties.
    Muroi M; Sano K; Okada G; Koshino H; Oku T; Takatsuki A
    J Antibiot (Tokyo); 2001 Jun; 54(6):489-93. PubMed ID: 11513037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel heme-containing protein with anti-HIV-1 activity from skin secretions of Bufo andrewsi.
    Zhao Y; Jin Y; Wang JH; Wang RR; Yang LM; Lee WH; Zheng YT; Zhang Y
    Toxicon; 2005 Nov; 46(6):619-24. PubMed ID: 16157359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of human immunodeficiency virus type-1-induced syncytium formation and cytopathicity by complestatin.
    Momota K; Kaneko I; Kimura S; Mitamura K; Shimada K
    Biochem Biophys Res Commun; 1991 Aug; 179(1):243-50. PubMed ID: 1715691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. How can (-)-epigallocatechin gallate from green tea prevent HIV-1 infection? Mechanistic insights from computational modeling and the implication for rational design of anti-HIV-1 entry inhibitors.
    Hamza A; Zhan CG
    J Phys Chem B; 2006 Feb; 110(6):2910-7. PubMed ID: 16471901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surface plasmon resonance analysis of gp17, a natural CD4 ligand from human seminal plasma inhibiting human immunodeficiency virus type-1 gp120-mediated syncytium formation.
    Autiero M; Gaubin M; Mani JC; Castejon C; Martin M; el Marhomy S; Guardiola J; Piatier-Tonneau D
    Eur J Biochem; 1997 Apr; 245(1):208-13. PubMed ID: 9128743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of type 1 inosine monophosphate dehydrogenase as an antiangiogenic drug target.
    Chong CR; Qian DZ; Pan F; Wei Y; Pili R; Sullivan DJ; Liu JO
    J Med Chem; 2006 May; 49(9):2677-80. PubMed ID: 16640327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.